BRIXELLE
LIVE

Serial Number

79302745

Owner

Bilix Co., Ltd.

Attorney

James R Menker

Filing Date

Dec 1, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BRIXELLE Trademark

Serial Number: 79302745 • Registration: 6822946

BRIXELLE is a trademark filed by Bilix Co., Ltd. on December 1, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Bilix Co., Ltd. (2 trademarks)

12th Fl., 364, Gangnam-daero, Gangnam-gu

Entity Type: 03

Trademark Details

Filing Date

December 1, 2020

Registration Date

August 23, 2022

Published for Opposition

June 7, 2022

Goods & Services

Pharmaceutical agents affecting sensory organs; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for peripheral nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; vaccines; anti-inflammatory preparations; medicines for intestinal disorders; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; enzymes for medical purposes; diagnostic preparations for medical or veterinary purposes; immunoassay reagents for medical use; medical reagents for testing genetic identity for medical purposes; pharmaceutical preparations for neurological disease; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for ocular and intraocular surgery; pharmaceutical preparations for rare autoimmune diseases in the nature of autoimmune lymphoproliferative syndrome, lupus, and multiple sclerosis; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for the prevention and treatment of rare genetic diseases affecting red blood cells; medicated ointments for treating dermatological conditions; antibiotic ointments; mentholated ointment for medical use; anti-inflammatory ointments; chemical reagents for purposes of medical diagnosis; diagnostic preparations for diagnosing inflammatory diseases; diagnostic radiopharmaceutical preparations; pharmaceutical and biological preparations for use in diagnosis, namely, for use as ultrasound and X-ray contrast reagents; human vaccine preparations; pharmaceutical preparations acting on the central nervous system; preparations for the treatment of asthma; medicines for dental purposes; dermatological pharmaceutical products; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; antibiotics; anti-cancer preparations; tumor suppressing agents; pharmaceutical products for treating respiratory diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 27, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 12, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 22, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 22, 2022 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
ASSIGNED TO LIE
May 2, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 27, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 29, 2021 GNFN
FINAL REFUSAL E-MAILED
Oct 29, 2021 GNFR
FINAL REFUSAL WRITTEN
Oct 29, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2021 TROA
REFUSAL PROCESSED BY IB
May 17, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 26, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 26, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 23, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 22, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 21, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 21, 2021 REPR